Advertisement
Singapore markets closed

  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     

  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     

  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Bitcoin USD

    64,024.12
    +1,142.77 (+1.82%)
     

  • CMC Crypto 200

    1,326.30
    +49.32 (+3.86%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • Dow

    38,675.68
    +450.02 (+1.18%)
     

  • Nasdaq

    16,156.33
    +315.37 (+1.99%)
     

  • Gold

    2,310.10
    +0.50 (+0.02%)
     

  • Crude Oil

    77.99
    -0.96 (-1.22%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     

  • Jakarta Composite Index

    7,134.72
    +17.30 (+0.24%)
     

  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Chemical company Platform to buy Arysta LifeScience for $3.5 billion

Reuters

(Reuters) - Specialty chemicals company Platform Specialty Products Corp (PAH.N) said it will buy rival Arysta LifeScience Ltd from a company backed by private equity firm Permira for about $3.51 billion (2.78 billion pounds).

The company said it expects the deal to immediately add to adjusted earnings per share. The deal is expected to be "highly complementary" to Platform's crop protection businesses.

Arysta is a global provider of agrochemical and biological products.

(Reporting By Shubhankar Chakravorty in Bangalore; Editing by Don Sebastian)